Prognostic Value of Soluble HLA-G and CD38 Expression in Patients with Chronic Lymphocytic Leukemia in Egypt | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 5, Volume 80, Issue 1, July 2020, Page 581-586 PDF (603.92 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejhm.2020.88564 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Omar Elhenawy Mohamed Thabet* 1; Wafaa Salah Mohamed1; Magda Assem2; Abdel Rahman Abdel Hamid3; Randa Amin Osman2 | ||||
| 1Department of Clinical Pathology, Faculty of Medicine – Aswan University | ||||
| 2Department of Clinical Pathology, National Cancer Institute – Cairo univeristy | ||||
| 3Department of Clinical Pathology, Faculty of Medicine – Qena University | ||||
| Abstract | ||||
| Background: Chronic lymphatic leukemia (CLL) is the most common hematological malignancy in adults presenting with varied clinical courses. There is an increased demand for establishing known prognostic factors for stratifying CLL patients. Aim of the work: To investigate the expression of soluble form of human leucocyte antigen-G (HLA-G) & CD 38 in CLL and to correlate our findings with a variety of clinical and laboratory variables. Patients and methods: The study included thirty newly diagnosed CLL patients. They were 18 males and 12 females with age ranged from 49–65 (a mean of 57.5 years old). Diagnosis of CLL was confirmed by flow cytometric immunophenotyping using standard lymphoma panel. CD38 expression was determined by flow cytometry. S. HLAG was measured by ELISA method. Results: Positive CD38 expression was significantly associated with lower Hb and platelets (p = 0.008 and 0.025 respectively) also with higher Beta2 microglobulin (p = 0.012). Soluble HLA G was positively correlated with the platelets count(r = 0.400, p = 0.02). Higher level of soluble form HLA-G was significantly more frequent in patients of 60 years or older (p = 0.001). The cumulative overall survival was 83.3%. Positive CD 38 expression was associated with significantly worse survival (p < 0.005). HB count < 10 gm/dl was associated with significantly worse survival (p < 0.001). Conclusion: CD38 expressions are considered powerful prognostic markers in predicting overall survival for Egyptian CLL patients and they should be assessed to decide the patient's therapy and to determine disease prognosis. Expression of soluble form of HLA-G in CLL patients by ELISA get no extra prognostic importance. | ||||
| Keywords | ||||
| CLL; HLA-G; CD38; ELISA | ||||
|
Statistics Article View: 310 PDF Download: 407 |
||||
